{
    "clinical_study": {
        "@rank": "134649", 
        "arm_group": {
            "arm_group_label": "Calcitriol ointment", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The objective of this study is to evaluate the safety and efficacy of up to 26 weeks of\n      treatment with calcitriol 3 mcg/g ointment when used twice daily, without occlusion, to\n      treat pediatric subjects (2 to 17 years of age) with mild to moderate plaque psoriasis."
        }, 
        "brief_title": "Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis", 
        "condition": "Psoriasis Vulgaris", 
        "condition_browse": {
            "mesh_term": "Psoriasis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female 2 to 17 years of age\n\n          -  Clinical diagnosis of stable mild to moderate plaque psoriasis\n\n        Exclusion Criteria:\n\n          -  Other forms of psoriasis\n\n          -  Hypercalcemia\n\n          -  Past history of kidney stones\n\n          -  Vitamin D deficiency\n\n          -  Other concomitant dermatological disease"
            }, 
            "gender": "Both", 
            "maximum_age": "17 Years", 
            "minimum_age": "2 Years"
        }, 
        "enrollment": {
            "#text": "140", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 28, 2014", 
        "id_info": {
            "nct_id": "NCT02125279", 
            "org_study_id": "RD.06.SPR.18131"
        }, 
        "intervention": {
            "arm_group_label": "Calcitriol ointment", 
            "intervention_name": "Calcitriol", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Calcitriol"
        }, 
        "lastchanged_date": "April 25, 2014", 
        "number_of_arms": "1", 
        "official_title": "A Multicenter Open Label Uncontrolled Study of the Long Term Safety and Efficacy of Calcitriol 3 mcg/g Ointment Applied Twice Daily for 26 Weeks in Pediatric Subjects (2 to 17 Years of Age) With Mild to Moderate Plaque Psoriasis", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "October 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Proportion of subjects with serum albumin-adjusted calcium higher than the upper normal limit and/or PTH levels below the lower limit of normal.\nIncidence of urolithiasis", 
            "measure": "Laboratory parameters related to calcium metabolism after 26 weeks of topical treatment with Calcitriol 3 mcg/g", 
            "time_frame": "Week 26"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02125279"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Galderma", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Galderma", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "N/A", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}